Browse Studies — Arctuva

Phase 1

Phase II Study Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers

Background: Cholangiocarcinoma (CCA) is an aggressive cancer of the bile ducts. People with CCA have few treatment options and poor survival. Researchers want…

CholangiocarcinomaBile Duct NeoplasmBiliary Tract Malignancy

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT04645160

Phase 2

Phase II Study Evaluating the Efficacy of PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Background: One way to treat liver cancer is to deliver chemotherapy drugs only to the liver (and not to the whole body). Researchers want to see if adding th…

Metastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT05286814

Phase 2

Incisional Hernia Prevention After Open Hepatectomy by Small Tissue Bite Fascial Closure: A Randomized Clinical Trial

This clinical trial compares two different kinds of surgical closing techniques, short stitch suture or traditional suture, in patients who are having liver tu…

Liver and Intrahepatic Bile Duct NeoplasmMetastatic Malignant Neoplasm in the LiverPrimary Malignant Liver Neoplasm

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT04982653